PL448581A1 - 2-(4-Hydroxy-3-nitrobenzoyl)-N-[(naphth-1-yl)methyl]hydrazinecarbothioamide, method of its production and its first medical application - Google Patents

2-(4-Hydroxy-3-nitrobenzoyl)-N-[(naphth-1-yl)methyl]hydrazinecarbothioamide, method of its production and its first medical application

Info

Publication number
PL448581A1
PL448581A1 PL448581A PL44858124A PL448581A1 PL 448581 A1 PL448581 A1 PL 448581A1 PL 448581 A PL448581 A PL 448581A PL 44858124 A PL44858124 A PL 44858124A PL 448581 A1 PL448581 A1 PL 448581A1
Authority
PL
Poland
Prior art keywords
reaction
hydrazinecarbothioamide
hydroxy
naphth
nitrobenzoyl
Prior art date
Application number
PL448581A
Other languages
Polish (pl)
Other versions
PL247927B1 (en
Inventor
Mariola Głowacka
Jolanta Łuniewska-Bury
Original Assignee
Akademia Mazowiecka W Płocku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademia Mazowiecka W Płocku filed Critical Akademia Mazowiecka W Płocku
Priority to PL448581A priority Critical patent/PL247927B1/en
Publication of PL448581A1 publication Critical patent/PL448581A1/en
Publication of PL247927B1 publication Critical patent/PL247927B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C337/00—Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C337/06—Compounds containing any of the groups, e.g. thiosemicarbazides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa pochodna hydrazynokarbotioamidu, o wzorze ogólnym 1 przedstawionym na rysunku, będąca jednoczesnym inhibitorem ludzkiej topoizomerazy II oraz tyrozynazy do zastosowania w leczeniu czerniaka. Zgłoszenie obejmuje także sposób wytwarzania nowej pochodnej hydrazynokarbotioamidu o wzorze ogólnym 1, charakteryzujący się tym, że hydrazyd kwasu 4-hydroksy-3-nitrobenzoesowego poddaje się reakcji z izotiocyjanianem 1-naftylometylu, prowadząc reakcję w rozpuszczalnikach organicznych, gdzie postęp reakcji kontroluje się przy użyciu technik chromatograficznych, a po zakończeniu reakcji mieszaninę reakcyjną ochładza się, powstały osad odsącza, suszy, a następnie krystalizuje z rozpuszczalników polarnych. Reakcję w rozpuszczalnikach organicznych prowadzi się we wrzącym etanolu, korzystnie w czasie przez 5 — 30 minut, zaś otrzymany produkt reakcji krystalizuje się z etanolu.The subject of the application is a new hydrazinecarbothioamide derivative, of general formula 1 shown in the drawing, being a simultaneous inhibitor of human topoisomerase II and tyrosinase for use in the treatment of melanoma. The application also covers a method of producing a new hydrazinecarbothioamide derivative of general formula 1, characterized in that 4-hydroxy-3-nitrobenzoic acid hydrazide is reacted with 1-naphthylmethyl isothiocyanate, carrying out the reaction in organic solvents, where the progress of the reaction is controlled using chromatographic techniques, and after the reaction is completed, the reaction mixture is cooled, the resulting precipitate is filtered off, dried, and then crystallized from polar solvents. The reaction in organic solvents is carried out in boiling ethanol, preferably for 5-30 minutes, and the obtained reaction product is crystallized from ethanol.

PL448581A 2024-05-15 2024-05-15 2-(4-Hydroxy-3-nitrobenzoyl)-N-[(naphth-1-yl)methyl]hydrazinecarbothioamide, method of its production and its first medical application PL247927B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL448581A PL247927B1 (en) 2024-05-15 2024-05-15 2-(4-Hydroxy-3-nitrobenzoyl)-N-[(naphth-1-yl)methyl]hydrazinecarbothioamide, method of its production and its first medical application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL448581A PL247927B1 (en) 2024-05-15 2024-05-15 2-(4-Hydroxy-3-nitrobenzoyl)-N-[(naphth-1-yl)methyl]hydrazinecarbothioamide, method of its production and its first medical application

Publications (2)

Publication Number Publication Date
PL448581A1 true PL448581A1 (en) 2024-12-02
PL247927B1 PL247927B1 (en) 2025-09-15

Family

ID=93706957

Family Applications (1)

Application Number Title Priority Date Filing Date
PL448581A PL247927B1 (en) 2024-05-15 2024-05-15 2-(4-Hydroxy-3-nitrobenzoyl)-N-[(naphth-1-yl)methyl]hydrazinecarbothioamide, method of its production and its first medical application

Country Status (1)

Country Link
PL (1) PL247927B1 (en)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GOOGLE; A. Szopa et al., Evaluation of developmental toxicity in zebrafish embryos and antiproliferative potential against human tumor cell lines of new derivatives containing 4-nitrophenyl group. Toxicol Appl Pharmacol. 2023 Jan; 458: 116325 *
GOOGLE; Kozyra et al., Potential Anticancer Agents against Melanoma Cells Based on an As-Synthesized Thiosemicarbazide Derivative. Biomolecules. 2022; 12(2):151 *
GOOGLE; M. Wos et al., Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity. Biomed Pharmacother. 2017; 93: 1269-1276 *

Also Published As

Publication number Publication date
PL247927B1 (en) 2025-09-15

Similar Documents

Publication Publication Date Title
KR100688740B1 (en) N-cyanomethyl amide as a protease inhibitor
EP1727808B3 (en) Biaryl amino acids and their use in dna binding oligomers
JP4351533B2 (en) Substituted thioacetamide
RU2319693C9 (en) Derivatives of urea (variants), pharmaceutical composition (variants) and method for treatment of diseases associated with cancer cells growth (variants)
DE69718472T2 (en) BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
DE60122939T2 (en) SUBSTITUTED ARYL COMPOUNDS AS NEW, CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS, AND USE PROCESSES
CA2769474C (en) Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
Zamani et al. Synthesis of some new substituted 1, 2, 4-triazole and 1, 3, 4-thiadiazole and their derivatives
US8383652B2 (en) Biaromatic compounds that modulate PPAR-receptors
KR20030029047A (en) Substituted Thioacetamides
BRPI0017535B1 (en) COMPOUND OF DIFENYL-UREAS REPLACED WITH? - CARBoxy-ARYLAS
AR126980A1 (en) SUBSTITUTED S-ALANINATE DERIVATIVES
PL448581A1 (en) 2-(4-Hydroxy-3-nitrobenzoyl)-N-[(naphth-1-yl)methyl]hydrazinecarbothioamide, method of its production and its first medical application
AU2005209257A1 (en) Vanilloid receptor ligands and their use in treatments
FR2930552A1 (en) N-ACYLTHIOUREES AND N-ACYLUREES INHIBITORS OF THE HEDGEHOG PROTEIN SIGNALING PATHWAY
PL448580A1 (en) 2-(3-Hydroxy-4-nitrobenzoyl)-N-[(naphth-1-yl)methyl]hydrazinecarbothioamide, method of its production and its first medical application
KR102882178B1 (en) Novel dipeptide compounds and their uses
Sharma et al. Synthesis of fluorophenothiazines via Smiles rearrangement and their conversion into sulfones
CN105814018B (en) New carbamide compounds, preparation method and its usage
JPH03178954A (en) Benzanilide
Gömeç et al. Designed, synthesis, in vitro and computational analyses of anticancer nicotinamide derivatives
CN107426996A (en) (S)‑2’‑Vinyl Abscisic Acid Derivatives
ES2017483B3 (en) ACIDS OF THE DYSELENOBIS BENZOIC ACID OF PRIMARY HETERO-CYCLIC AMINES, PROCESS FOR THE PRODUCTION OF THE SAME, AND PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM.
Mlostoń et al. Synthesis of optically active trifluoromethyl-substituted 2, 3-dihydroimidazo [2, 1-b] oxazoles
PL428850A1 (en) 1,4-disubstituted thiosemicarbazide derivative, method of its preparation and its medical use